CETP Inhibitors - A New Inning?

被引:20
|
作者
Hegele, Robert A. [1 ]
机构
[1] Schulich Sch Med & Dent, Dept Med, London, ON, Canada
关键词
HIGH-RISK;
D O I
10.1056/NEJMe1711407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1284 / 1285
页数:2
相关论文
共 50 条
  • [1] The new hopes of CETP inhibitors
    Farnier, M.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2012, 16 (04): : 98 - 100
  • [2] CETP inhibitors revisited
    Laufs, Ulrich
    Speer, Thimoteus
    EUROPEAN HEART JOURNAL, 2022, 43 (14) : 1425 - 1427
  • [3] Trials and Tribulations of CETP Inhibitors
    Tall, Alan R.
    Rader, Daniel J.
    CIRCULATION RESEARCH, 2018, 122 (01) : 106 - 112
  • [4] Obicetrapib-the Rebirth of CETP Inhibitors?
    Chang, Bliss
    Laffin, Luke J.
    Sarraju, Ashish
    Nissen, Steven E.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (10) : 603 - 608
  • [5] The effect of CETP inhibitors on new-onset diabetes: a systematic review and meta-analysis
    Dangas, Katerina
    Navar, Ann-Marie
    Kastelein, John J. P.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (06) : 622 - 632
  • [6] CETP Inhibitors: Should We Continue to Pursue This Pathway?
    Nicholls, Stephen J.
    Nelson, Adam J.
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (12) : 915 - 923
  • [7] The mystery of evacetrapib-why are CETP inhibitors failing?
    Nicholls, Stephen J.
    Bubb, Kristen
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (03) : 127 - 130
  • [8] Can we revive CETP-inhibitors for the prevention of cardiovascular disease?
    Nicholls, Stephen J.
    Ray, Kausik K.
    Nelson, Adam J.
    Kastelein, John J. P.
    CURRENT OPINION IN LIPIDOLOGY, 2022, 33 (06) : 319 - 325
  • [9] Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective
    Mohammadpour, Amir Hooshang
    Akhlaghi, Fatemeh
    CLINICAL PHARMACOKINETICS, 2013, 52 (08) : 615 - 626
  • [10] CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITORS AND THEIR ROLE IN CARDIOVASCULAR DISORDERS
    Kontush, A.
    DRUGS OF THE FUTURE, 2011, 36 (05) : 377 - 384